Login to Your Account



Biovail Gains Newly Approved HD Drug in $100M Prestwick Buyout

By Jennifer Boggs


Thursday, September 18, 2008
A month after winning FDA approval for its first drug, privately held Prestwick Pharmaceuticals Inc. was acquired by Canadian drugmaker Biovail Corp. in a $100 million deal. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription